Dr. Violeta Isabel Perez Nueno is working at World Health Organisation (WHO), Prequalification/Vector Control Products Assessment Team as Scientist (Product Chemistry and Manufacturing).Previously she worked at the WHO Immunization, Vaccines and Biologicals Department (IVB), WHO Digital Health and Innovation Department (DHI), at Be He@lthy, Be Mobile (BHBM) and Strategy and Governance Teams, supporting the development of regional and national digital health strategy plans, establishing digital health governance in support of primary health care, universal health coverage as well as preparedness for emergencies, promoting standards for safety, security, privacy, interoperability, confidentiality and the ethical use of data, helping countries to achieve digital health transformation by means of capacity building, implementation, deployment of digital health solutions, assessment of the digital maturity level and the implementation of digital health and innovation strategies through standard agreed-upon metrics. Before she was Programme Officer – EU Policies and Research Coordinator in charge of the in silico medicine portfolio at the European Commission – DG CONNECT Dir H – Digital Society, Trust and Cybersecurity Unit H.3 – E-Health, Well-Being and Ageing (previously working at EC – DG CONNECT Dir A – Digital Industry Unit A.1 – Robotics and Artificial Intelligence Robotics Industrial Development and Impact) dealing with programme management, policy development and programme dissemination. She was topic coordinator, managing research grants/projects, contributing to research strategy, drafting topics for future EU Financial Framework Programmes, developing/contributing to policy measures and their implementation, and representative of the European Commission in Strategic Governing Groups.
She received her European Ph.D. and Postdoc in life sciences, organic chemistry and biochemistry program, chemoinformatics and drug design specialty in 2009 and 2011. During that period, she participated in two research projects promoted by the Catalan Government and the Spanish Ministry of Science, she was involved in international scientific collaborations (UK, Italy, and France), and she was awarded three times for her work on anti-HIV drugs (XII Premio de Investigación Dr. Antonio Esteve, EXPOQUIMIA I+D+i 2011 award, PhD Extraordinary Award from the Ramon Llull University). After, she was engaged as associate professor in computational chemistry (Universitat Ramon Llull, Barcelona Spain). In 2010, she obtained a postdoctoral grant from the Catalan Parliament, and a Marie Curie IEF for a research position in the Orpailleur Team, at the Lorraine Research Laboratory in Computer Science and its Applications (LORIA), Nancy, France. She also stayed at IGMM-CNRS and Institut des Biomolécules Max Mousseron (IBMM), Montpellier, during 7 months as mission inside FP7 IEF Marie Curie Fellow. During the postdoctoral period, she supervised two master theses, a thesis, examined two theses, and participated in four new research projects. She was awarded for her polypharmacology work (Medicinal Chemistry Conference, 2012). She joined Harmonic Pharma SAS from July 2012 to July 2015. She organized symposia in international scientific conventions such as ACS, ICDDT, ICCMSE, and IWBBIO Meetings. V.I. Pérez-Nueno has 38 international publications (28 in international leading journals), 1 book chapter, 3 patents, and her scientific work has been recognized several times as ACS Journal Front Covers. In 2016-2018 she performed a Master in Health Economics and Pharmacoeconomics and in 2021 a Master in Nutrition and Health. She joined Kalispera Medical Writing as medical writer in September 2016. In 2017 she joined the European Commission. In 2020 she joined WHO. Always ready to go further and learn more.
Fields of expertise:
“Programme and project management”, “Research coordination”, “EU policies”, “Communication and dissemination of policy and research”, “e-health”, “mhealth”, “standards for safety, security, privacy, interoperability, confidentiality and the ethical use of data”, “strategy and governance”,”AI for health”, “Nutrition and health”, “Health economics and pharmacoeconomics”, “Research and innovation”, “Policy development”, “Programme dissemination”, “In silico medicine”, “Virtual Physiological Human”, “In silico drug repurposing at a pharma company”, “Network Pharmacology” , “Polypharmacy” , I have organised several sessions regarding QSP (Quantitative Systems Pharmacology) at the ACS (American Chemical Society) and European conferences, and “reducing inappropriate prescription in the Elderly” (Spanish ministry project MINI-MED, a tool for rationally reducing inappropriate prescription medication in the Elderly, to help doctor decisions, which in turn reduces side effects and money for national health systems), 2 Spanish Ministry projects on drug design for HIV inhibitors and 3 patents on HIV inhibitors and cancer inhibitors.
